Clinical Trial Update: Breathlessness Exertion and Morphine Sulphate [Phase 3]

View source ↗

Summary

Phase 3 trial update for morphine sulfate targeting breathlessness in COPD patients with dyspnea; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Dyspnea

Drugs mentioned

• Morphine Sulphate (morphine sulfate)

Snippet

Sponsor: Flinders University | Conditions: Chronic Obstructive Pulmonary Disease, Dyspnea | Phase 3 | Status: COMPLETED